Private Capital Management (Minnesota)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$255K Sell
4,000
-5,150
-56% -$301K 0.29% 139
2017
Q2
$510K Hold
9,150
0.57% 78
2017
Q1
$498K Buy
9,150
+300
+3% +$16.5K 0.54% 78
2016
Q4
$517K Sell
8,850
-2,800
-24% -$153K 0.58% 69
2016
Q3
$629K Buy
+11,650
New +$748K 0.66% 59

Other funds holding BMY

Private Capital Management (Minnesota)'s BMY Position: Q3 2017 in Review

Private Capital Management (Minnesota) reduced its Bristol-Myers Squibb (BMY) stake by 56% in Q3 2017, selling an estimated $301K and leaving 4,000 shares worth $255K. The position accounts for 0.29% of the portfolio, ranked #139.

Private Capital Management (Minnesota) first reported a position in BMY in Q3 2016 and has held it in 5 quarters since. The position peaked at $629K in Q3 2016. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Private Capital Management (Minnesota) held 4,000 shares of Bristol-Myers Squibb worth $255K as of Q3 2017.
  • Private Capital Management (Minnesota) sold 5,150 Bristol-Myers Squibb shares in Q3 2017, an estimated $301K.
  • Bristol-Myers Squibb made up 0.29% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #139 holding.
  • Private Capital Management (Minnesota) first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 5 quarters since.
  • Private Capital Management (Minnesota)'s Bristol-Myers Squibb position peaked at $629K in Q3 2016.
  • 1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.